Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Patient preferences regarding recontact by cancer genetics clinicians.

Griffin CA, Axilbund JE, Codori AM, Deise G, May B, Pendergrass C, Tillery M, Trimbath JD, Giardiello FM.

Fam Cancer. 2007;6(3):265-73. Epub 2007 Feb 17.

PMID:
17308889
2.

Genetic counseling outcomes: perceived risk and distress after counseling for hereditary colorectal cancer.

Codori AM, Waldeck T, Petersen GM, Miglioretti D, Trimbath JD, Tillery MA.

J Genet Couns. 2005 Apr;14(2):119-32.

PMID:
15959643
3.

Prevalence of major depression one year after predictive testing for Huntington's disease.

Codori AM, Slavney PR, Rosenblatt A, Brandt J.

Genet Test. 2004 Summer;8(2):114-9.

PMID:
15345107
4.

Genetic testing for hereditary colorectal cancer in children: long-term psychological effects.

Codori AM, Zawacki KL, Petersen GM, Miglioretti DL, Bacon JA, Trimbath JD, Booker SV, Picarello K, Giardiello FM.

Am J Med Genet A. 2003 Jan 15;116A(2):117-28.

PMID:
12494429
5.

Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals.

Brandt J, Shpritz B, Codori AM, Margolis R, Rosenblatt A.

J Int Neuropsychol Soc. 2002 Nov;8(7):918-24.

PMID:
12405543
6.

Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention.

Codori AM, Petersen GM, Miglioretti DL, Boyd P.

Prev Med. 2001 Aug;33(2 Pt 1):128-36.

PMID:
11493046
7.

Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.

Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, Barta PE, Pearlson GD, Ross CA.

Mov Disord. 2000 May;15(3):552-60.

PMID:
10830423
8.

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease.

Harris GJ, Codori AM, Lewis RF, Schmidt E, Bedi A, Brandt J.

Brain. 1999 Sep;122 ( Pt 9):1667-78.

PMID:
10468506
9.

Attitudes toward colon cancer gene testing: factors predicting test uptake.

Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, Brensinger JD, Johnson K, Bacon JA, Booker SV.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):345-51.

10.

Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.

Petersen GM, Larkin E, Codori AM, Wang CY, Booker SV, Bacon J, Giardiello FM, Boyd PA.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):337-44.

11.

When does Huntington's disease begin?

Campodonico JR, Aylward E, Codori AM, Young C, Krafft L, Magdalinski M, Ranen N, Slavney PR, Brandt J.

J Int Neuropsychol Soc. 1998 Sep;4(5):467-73.

PMID:
9745236
12.

Psychological opportunities and hazards in predictive genetic testing for cancer risk.

Codori AM.

Gastroenterol Clin North Am. 1997 Mar;26(1):19-39. Review.

PMID:
9119438
13.

Predictors of psychological adjustment to genetic testing for Huntington's disease.

Codori AM, Slavney PR, Young C, Miglioretti DL, Brandt J.

Health Psychol. 1997 Jan;16(1):36-50.

PMID:
9028814
14.

Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation.

Campodonico JR, Codori AM, Brandt J.

J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):621-4.

15.

Basal ganglia volume and proximity to onset in presymptomatic Huntington disease.

Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J.

Arch Neurol. 1996 Dec;53(12):1293-6.

PMID:
8970459
16.

Genetic testing for cancer in children. Short-term psychological effect.

Codori AM, Petersen GM, Boyd PA, Brandt J, Giardiello FM.

Arch Pediatr Adolesc Med. 1996 Nov;150(11):1131-8.

PMID:
8904852
17.

Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.

Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, et al.

Am J Hum Genet. 1995 Sep;57(3):593-602.

18.

Psychological costs and benefits of predictive testing for Huntington's disease.

Codori AM, Brandt J.

Am J Med Genet. 1994 Sep 15;54(3):174-84.

PMID:
7810575
19.

Self-selection in predictive testing for Huntington's disease.

Codori AM, Hanson R, Brandt J.

Am J Med Genet. 1994 Sep 15;54(3):167-73.

PMID:
7810574
20.

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ.

Neurology. 1994 May;44(5):823-8.

PMID:
8190282
21.

Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease.

Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S.

Arch Neurol. 1993 Aug;50(8):799-802. Erratum in: Arch Neurol 1994 Mar;51(3):268.

PMID:
8352663

Supplemental Content

Loading ...
Support Center